Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 30 institutions reported holding it in 13F filings for Q2 2023, worth $10.5M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Axcella Health Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
AXLA is no longer listed, and 13F filings after Q2 2023 list far fewer holders. See Q2 2023
- Institutional holders
- 1
- 0 vs. Q2 2024
- Shares held
- 80
- 0 (0.0%) vs. Q2 2024
- Total value
- $0
- $0 vs. Q2 2024
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $32 |
| Q3 2023 | 1 | $835 |
| Q2 2023 | 30 | $10.5M |
| Q1 2023 | 29 | $23.6M |
| Q4 2022 | 35 | $15.9M |
| Q3 2022 | 34 | $58.3M |
| Q2 2022 | 34 | $69.2M |
| Q1 2022 | 38 | $87.0M |
| Q4 2021 | 35 | $50.4M |
| Q3 2021 | 35 | $71.6M |
| Q2 2021 | 38 | $97.3M |
| Q1 2021 | 44 | $121.7M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Axcella Health Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lindbrook Capital, LLC | 80 | $0 | 0.00% | 00.0% | Unchanged |